Apoptosis Imaging by ML-10-PET: From the Bench to the Clinic - Part 1

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
488 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 15, 2010

Dr. Miri Ben-Ami, Vice President for Clinical Development and Regulatory Affairs with Aposense, Ltd., discusses the "bench to clinic" applications of Apoptosis Imaging using ML-10 PET in the Emerging Technologies Session at the 2010 SNM Annual Meeting. This lecture reviews the function of apoptosis and how it can be used to evaluate treatment effects for different types of disease. Dr. Ben-Ami also reviews the completed trial results of the ML-10 tracer and current and proposed trial information of ML-10. ML10 is an investigational drug and not currently approved by the FDA. IBA Molecular North America, Inc. (and its affiliates) have a business relationship with Aposense for ML-10 PET.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Very convincing and encouraging. Seems like there's a lot of potential in this area. We should watch this space. Excellent delivery by the speaker.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more